Clinical study of topotecan and cisplatin as first line chemotherapy in epithelial ovarian cancer

Zhonghua fu chan ke za zhi

Volumn 42, Issue 10, 2007, Pages 683-687

  Meng, Li Hua ^a   Kong, Bei Hua ^a   Zhang, You Zhong ^a   Yang, Xing Sheng ^a   Wang, Li Jie ^a   Su, Shi Li ^a   Jiang, Jie ^a   Cui, Bao Xia ^a   Wang, B ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; PACLITAXEL; TOPOTECAN;

ARTICLE; CANCER STAGING; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; COMPARATIVE STUDY; CYSTADENOCARCINOMA; DISEASE FREE SURVIVAL; DRUG ADMINISTRATION; FEMALE; FEVER; FOLLOW UP; HUMAN; LEUKOPENIA; MIDDLE AGED; MORTALITY; NEUTROPENIA; OVARY TUMOR; PATHOLOGY; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYSTADENOCARCINOMA, SEROUS; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; FEVER; FOLLOW-UP STUDIES; HUMANS; LEUKOPENIA; MIDDLE AGED; NEOPLASM STAGING; NEUTROPENIA; OVARIAN NEOPLASMS; PACLITAXEL; PROGNOSIS; SURVIVAL RATE; TOPOTECAN; TREATMENT OUTCOME;

EID: 54049088605     PISSN: 0529567X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)